Aerie Pharmaceuticals, Inc. (AERI)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
16.21+0.09 (+0.56%)
At close: 4:00PM EDT
Currency in USD
Valuation measures
| Market cap (intra-day) 5 | 760.14M |
| Enterprise value 3 | 777.77M |
| Trailing P/E | N/A |
| Forward P/E 1 | -11.42 |
| PEG ratio (5-yr expected) 1 | 0.11 |
| Price/sales (ttm) | 8.86 |
| Price/book (mrq) | N/A |
| Enterprise value/revenue 3 | 9.07 |
| Enterprise value/EBITDA 7 | -7.00 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.72 |
| 52-week change 3 | 3.33% |
| S&P500 52-week change 3 | 36.35% |
| 52-week high 3 | 21.30 |
| 52-week low 3 | 9.01 |
| 50-day moving average 3 | 16.67 |
| 200-day moving average 3 | 16.51 |
Share statistics
| Avg vol (3-month) 3 | 482.71k |
| Avg vol (10-day) 3 | 471.38k |
| Shares outstanding 5 | 46.89M |
| Implied shares outstanding 6 | N/A |
| Float | 45.81M |
| % held by insiders 1 | 2.38% |
| % held by institutions 1 | 108.14% |
| Shares short (27 May 2021) 4 | 6.48M |
| Short ratio (27 May 2021) 4 | 13.5 |
| Short % of float (27 May 2021) 4 | 14.15% |
| Short % of shares outstanding (27 May 2021) 4 | 13.82% |
| Shares short (prior month 29 Apr 2021) 4 | 6.7M |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | N/A |
| Trailing annual dividend yield 3 | N/A |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Fiscal year
| Fiscal year ends | 30 Dec 2020 |
| Most-recent quarter (mrq) | 30 Mar 2021 |
Profitability
| Profit margin | -205.13% |
| Operating margin (ttm) | -170.19% |
Management effectiveness
| Return on assets (ttm) | -23.54% |
| Return on equity (ttm) | -301.15% |
Income statement
| Revenue (ttm) | 85.77M |
| Revenue per share (ttm) | 1.87 |
| Quarterly revenue growth (yoy) | 12.90% |
| Gross profit (ttm) | 55.5M |
| EBITDA | -111.08M |
| Net income avi to common (ttm) | -175.94M |
| Diluted EPS (ttm) | -3.83 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 208.2M |
| Total cash per share (mrq) | 4.44 |
| Total debt (mrq) | 230.05M |
| Total debt/equity (mrq) | N/A |
| Current ratio (mrq) | 3.14 |
| Book value per share (mrq) | -0.22 |
Cash flow statement
| Operating cash flow (ttm) | -52.92M |
| Levered free cash flow (ttm) | -33.42M |
© 2021 Verizon Media. All rights reserved.
